Guidelines
1 Operator’s qualifications
A specific qualification in level I digestive endoscopy is required for performing
a colonoscopy. This qualification can only be validated if the doctor acquired
the certification in hepatogastroenterology.
When performing the examination, it is advisable to have an assistant present
who is familiar with endoscopy. He or she can help when advancing the endoscope
(abdominal pressure), performing diagnostic or therapeutic procedures, etc.
2 Indication
The indication for a colonoscopy must be made or confirmed by an hepatogastroenterologist,
bearing in mind the patient’s characteristics, the present state of knowledge
and current guidelines.
Indications for endoscopy of the lower digestive tract, aside from population
screening, were recently set out in the Clinical Practice Guidelines published
under the authority of the HAS in 2004 [1].
When used for population screening, a colonoscopy is indicated in case of positive
fecal occult blood test.
Colonoscopy is contraindicated if there is suspected perforation. The indication
for a colonoscopy must be considered carefully in cases of confirmed pregnancy,
suspected occlusion, severe inflammatory bowel disease, diverticulitis or known
aortic aneurysm.
3 Information to the patient
In France, according to the law of 4 March 2002, ”the patient must be given appropriate
information about the risks and benefits of the examination so that he or she
can give his informed consent”. According to the recommendations of the Haute
Autorité de Santé, this information must be given verbally, together with a written
document such as the information sheet proposed by the SFED in conjunction with
the SNFGE and the SNFCP. The information sheet does not need to be signed by the
patient. Proof that the information has been given can be supplied by ”any means”.
Written proof that the information has been given to the patient should be kept
with the medical records. If an appended document must be signed by the patient,
it can only validate the fact that the patient has received the information and
that he was given an opportunity to ask any questions he liked. Alternatives are
possible, such as a note in the medical records or in a letter to the attending
doctor.
Apart from an emergency, reasonable application of the law of 4 March 2002 implies
that information about the colonoscopy should be provided at a previous consultation,
specific or not, carried out by an hepatogastroenterologist. The same applies
to repeated colonoscopies.
At this consultation, essential questions regarding the risk of Creuzfeldt-Jakob’s
disease can be asked and the appropriate form on Creuzfeldt-Jakob’s disease risk
completed and be included with the records.
4 Bowel preparation [1]
[3]
[4]
[5]
[6]
[7]
This is a fundamental step for the examination. The consequences of poor preparation
are manifold (unrecognized lesions, greater septic risk in case of perforation,
need to repeat the examination, economic impact, etc.).
Apart from special cases, the bowel must be prepared orally using a product of
proven effectiveness. The two most frequently used products at the moment are
polyethylene glycol (PEG) and sodium phosphate.
Published studies show that there is no significant advantage in adding a non-fibrous
diet. However, it may help to cut down on fiber residues which are likely to interfere
with the examination. It is thus advisable and should be recommended for preparing
patients for whom there is a risk of failure (hospitalized patients, those taking
tricyclic antidepressants, with chronic constipation, etc.).
Due to the coloration they induce, it is advisable to withdraw drugs containing
iron a week before the investigation.
In addition to a verbal explanation, the patient must have accurate written information
about bowel preparation and any related diet.
There must be an interval between the final oral administration of the preparation
product and anaesthesia so that the preparation is emptied from the stomach. The
usual interval is three hours but this can vary according to the situation.
It is advisable to check the quality of the preparation before settling the patient.
If stools or dirty fluid is still being emitted, there are various options to
choose from: additional treatment by enema, postponed examination with extra oral
preparation, etc.
During the examination, the presence of solid residue which cannot be suctioned
is indicative of poor preparation; the operator must evaluate how damaging this
is to the effectiveness and safety of the procedure and whether he can continue
the examination or not, according to the circumstances. It is left to his judgement
as to whether another examination is scheduled.
5 Pre-colonoscopy blood test
There are no guidelines on performing blood tests before a colonoscopy.
The SFED has asked the Study Group on Haemostasis and Thrombosis (GEHT) for guidelines
to be put forward by specialists in haemostasis. Until this document is forthcoming,
any blood tests are left to the judgement of the operator and the anaesthetist.
6 Medical treatments
6.1 Antithrombotic treatment
Treatment should be adapted to comply with the guidelines on treatment with
anticoagulants and antiplatelet agents [8], published in 2005 and drawn up in consultation with the SFED, the French
Society of Anesthesiologist, the French Society of Cardiology and the GEHT.
6.2 Other treatment
At the anaesthesia consultation, treatments likely to interfere with the constraints
of anaesthesia have to be adapted (anaesthetics used, fasting, etc.).
7 Antibiotic prophylaxis
Antibiotic prophylactic treatment should be carried out in accordance with the
current guidelines (including the SFED guideline [9]) and with the anaesthetist.
8 Anaesthesia
The use of a general anaesthesia for colonoscopy has been demonstrated effective
on acceptability for the patient but up to now not on the quality of the examination.
In France, most examinations are performed under general anaesthesia with an anaesthetist
present. All patients undergoing a colonoscopy must be offered a general anaesthesia.
However, an examination without general anaesthesia is conceivable for patients
who have been told about the potential pain. Intravenous sedation by a doctor
who is not an anaesthetist is not recommended outside of clinical trials.
When an anaesthesia is used, additional safety conditions inherent with this practice
must be observed, in addition to those necessary for the colonoscopy itself. Specific
information about anaesthesia is given to the patient during a specific consultation
with an anaesthetist.
9 Facilities
If the patient received anaesthesia, the colonoscopy must be performed in an approved
facility for anesthesia. If the patient does not receive anaesthesia, the hepatogastroenterologist
is obliged to arrange the place, equipment and technical conditions for performing
the procedure.
10 Equipment
a) Endoscopes
A colonoscope is most often used. A gastroscope, a rectosigmoidoscope, or an
enteroscope (double balloon) may be preferable in particular situations.
There have been no scientific studies on correlations between obsolescence of
the equipment and the quality of the examination. However, equipment should
be upgraded regularly due to changing technology, particularly regarding the
image.
Preventive maintenance of endoscopes is advisable. It should be adapted to take
account of various factors (use, number of operators, age of the equipment,
etc.)
The overall equipment must consist of several endoscopes so that there is sufficient
time for cleaning and disinfecting the equipment in accordance with current
legal requirements and to adapt to any unexpected technical fault rendering
an endoscope unusable, without disrupting the endoscopy schedule and putting
patients at a disadvantage.
b) Accessories
Biopsy forceps (AFSSAPS decision 18 June 2001) and injection needles for mucosectomy
must be disposable. With regard to other accessories, circular DGS (Direction
Generale de la Santé) 138 recommends that they should be disposable as soon
as possible.
c) Handling the equipment
The procedures for cleaning, disinfecting and/or sterilising endoscopy equipment
must be performed and recorded, in compliance with current legislation (circulars
DGS 138 and 591). Cleaning/disinfecting procedures can be performed manually,
semi-automatically or may be completely automatic (washers-disinfectors).
d) Electrocoagulator
There must be an electrocoagulator in every examination room.
The choice of equipment and how it is used are covered in an SFED guideline
[10].
11 The method for advancing the endoscope
The examination is only regarded as complete if the caecum has been explored properly.
Generally, it is advisable to advance the endoscope by visualising the lumen,
by delooping, with limited inflation and suctioning any fluid which may be present.
Almost without exception, the use of radioscopy is not recommended. Some maneuvers
can sometimes be useful (changing the patient’s position, abdominal pressure,
etc.), particularly if there are circumstances which make advancement difficult
(history of pelvic surgery etc. [11]).
12 Examination of the mucosa [1]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
Examination of the mucosa must be very careful, circumferential and as complete
as possible (particularly behind the haustrations). It is carried out when the
endoscope is withdrawn, with alternating insufflation and exsufflation and by
examining the mucosa on the way down and up. It must be looked for relief abnormalities
(raised or depressed areas) but also for abnormalities in colour. Caecal and/or
rectal retrovision may be used with caution.
The time spent on examining the colon as the colonoscope is withdrawn increases
the method’s sensitivity. A minimum of 6 minutes, apart from special cases, is
recommended for exploring the mucosa when the endoscope is withdrawn.
Examination of the mucosa can be facilitated by chromoscopy. This is usually performed
with indigo carmine applied to the mucosa. Two successive passages are necessary,
first without chromoscopy then with chromoscopy, as a standard colonoscopy must
first be performed to ensure that colour abnormalities which could be masked by
the blue are not missed. It is recommended in screening for neoplastic lesions
in very high-risk groups: HNPCC syndrome or attenuated familial adenomatous polyposis.
While promising, application to long standing ulcerative colitis and Crohn’s disease
has still to be further evaluated before recommending chromoscopy to replace random
biopsies. It can also be useful in identifying the extent of flat lesions or in
investigating neoplastic residual foci after endoscopic resection.
It is advisable to exsufflate the colon at the end of the examination.
13 Associated procedures
-
Biopsies [1]
[25]
It is not advisable to systematically perform a biopsy of the ileum.
-
Resection of superficial neoplastic lesions [26]
Polypectomy and mucosectomy methods are described in specific SFED guidelines.
14 Post-colonoscopic monitoring and detection of complications
In addition to the monitoring specific to anaesthesia, monitoring of the endoscopic
procedure itself must be performed by the operator or a member of the medical
team before the patient is discharged so that any complications can be detected.
A document must be given to the patient with post-examination instructions and
the name and details of the person or institution to contact if he has any symptoms.
If there is any doubt about perforation, an abdomino-pelvic CT scan should be
favoured over a plain X-ray of the abdomen, as soon as possible. Failing that,
the indications for plain X-ray of the abdomen would still apply.
15 Traceability
All parameters of the endoscopic procedure must be registered. A guide to good
practice on this subject is currently being compiled. At present, the following
must be collected for each procedure: the patient’s name, the type of procedure
performed, the names of the medical and paramedical staff who performed the endoscopy
and anaesthesia, the timetables, the references of the endoscope and batch numbers
of the accessories used. The traceability of endoscope disinfection (manual or
automatic) must also be recorded in detail (products, decontamination and disinfection
times, etc.).
16 Final report
This is a key element in highlighting the quality of the procedure. It must give
details of the indication, the technical conditions of the exploration (quality
of the preparation, areas explored etc.), and the clinical outcome (location,
size, number and accurate description of neoplastic lesions; description of non-neoplastic
abnormalities: inflammatory lesions, diverticuli, angiodysplasia etc.). The description
of neoplastic lesions can be standardized according to the Paris classification.
It is advisable to have equipment for taking photographs.
17 Final correspondence
This has to be sent to the attending doctor. It should include the final report,
histological results and any comments about the treatment or subsequent monitoring
of the patient.
An additional letter can be sent to the patient automatically or in the absence
of an attending doctor. It can contain a copy of the final report and appropriate
explanatory comments, comments on histology and instructions on subsequent treatment
or monitoring.
The results can also be delivered to the patient himself following the examination
or at a later consultation. This dedicated consultation carried out by an hepatogastroenterologist,
is recommended in cases of resection or biopsy of a malignant lesion (high-grade
dysplasia, invasive cancer). The indications for this consultation can be extended,
in particular, if a chronic inflammatory bowel disease is discovered.
